Guaifenesin PDF

Preview

Summary

Guaifenesin med card...

Description

CLASS: Expectorant MOA:

GENERIC NAME: Guaifenesin

TRADE NAMES: Mucinex

Reduces the viscosity of secretions, makes coughs more productive INDICATIONS: Relief of productive cough associated with the common cold, bronchitis, laryngitis, pharyngitis, pertussis, influenza, and measles CONTRAINDICATIONS/PRECAUTIONS: Pregnancy, phenylketonuria, alcohol intolerance, nephrolithiasis, children younger than 6 years of age INTERACTIONS with other Drugs/Substances: No significant interactions PATIENT RESPONSE / COMMON SIDE ADVERSE REACTIONS: S/S TOXICITY: REACTIONS: EFFECTS: DESIRED OUTCOME: Rash, urticaria, N/A GI upset (nausea, nephrolithiasis Easier mobilization and vomiting, stomach pain, expectoration of mucus from diarrhea), dizziness, cough associated with upper headache respiratory infection. NURSING ACTIONS: PO (Adults): 200-400 mg every 4 hr or 600-1200 mg every 12 hr as extended-release product (not to exceed 2400 mg/day). PO (Children 6-12 yr): 100-200 mg every 4 hr or 600 mg every 12 hr as extended-release product (not to exceed 1200 mg/day).

ASSESS:

CARE/IMPLEMENT:

Assess lung sounds, frequency and type of cough, and character of bronchial secretions periodically during therapy.

Administer with a full glass of water

Maintain fluid intake of 1500-2000 mL/day to decrease viscosity of secretions.

TEACH: nstruct patient to cough effectively. Patient

High Alert: Do not

should sit upright and

confuse guaifenesin with

take several deep

guanfacine.

breaths before

PO: Administer each dose of guaifenesin followed

attempting to cough. Caution parents to avoid

by a full glass of water to

OTC cough and cold

decrease viscosity of

products while breast

secretions.

TOXICITY/OVERDOSE TX: N/A

EVALUATE: Easier mobilization and expectoration of mucus from cough associated with upper respiratory infection.

PO (Children 4-6 yr): 50-100 mg every 4 hr (not to exceed 600 mg/day).

feeding or administering Extended-release tablets

to children...